Home
MYNZ

MYNZ

Mainz Biomed N.V.

as of 12-03-2025 4:00pm EST

$1.16

$0.00

0.00%

Stocks Health Care Biotechnology: Pharmaceutical Preparations Nasdaq

Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The company's flagship product is ColoAlert, is an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal cancer based on real-time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in stool samples. The company operates in one operating segment, genetic diagnostic testing.

Chart Type:

Time Range:

Founded:	2021	Country:	Germany
Employees:	N/A	City:	N/A
Market Cap:	5.8M	IPO Year:	2021
Target Price:	$14.00	AVG Volume (30 days):	928.5K
Analyst Decision:	Strong Buy	Number of Analysts:	1
Dividend Yield:	N/A	Dividend Payout Frequency:	N/A
EPS:	-8.39	EPS Growth:	N/A
52 Week Low/High:	$0.92 - $8.20	Next Earning Date:	12-29-2025
Revenue:	$659,935	Revenue Growth:	-28.05%
Revenue Growth (this year):	-0.28%	Revenue Growth (next year):	5.03%

AI-Powered MYNZ Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated a day ago

AI Recommendation

hold

Model Accuracy: 69.18%

69.18%

Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

View Full MYNZ Forecast & Prediction with Hourly Data

Compare MYNZ vs Leading Stocks

See how MYNZ stacks up against similar companies in the market

Share on Social Networks:

Tools & Resources

Enhance your trading experience with our free tools

Free MYNZ Stock Widget

Embed our interactive stock ticker widget on your website for real-time updates.

Free Tool

Stock Alerts on Telegram

Get instant notifications, market insights, and expert analysis delivered to your phone.

Live Updates

Disclaimer

The information presented on this page, "MYNZ Mainz Biomed N.V. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.